Solara Active Pharma Sciences

502.50
-8.15
(-1.60%)
Market Cap
1,811.73 Cr
EPS
-157.62
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
882.80
52 Week low
327.22
PB Ratio
1.71
Debt to Equity
0.83
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
SELL
Analysts have suggested that investors can sell this stock
Buy0.0 %
0.0 %
Hold0.0 %
0.0 %
Sell100.00 %
100.00 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,664.00 3,99,249.34 33.68 49,887.20 12.06 9,648 13.77 47.46
5,507.70 1,46,212.13 71.18 8,184.00 0.89 1,600 64.53 40.99
1,450.05 1,17,108.07 23.41 26,520.70 14.17 4,155 47.38 48.78
3,071.60 1,03,956.90 55.61 10,785.70 11.59 1,656 13.54 47.28
1,094.15 91,297.07 17.35 28,905.40 12.36 5,578 1.69 31.30
2,166.35 89,376.43 44.67 10,615.60 19.57 1,942 -16.38 33.38
1,951.35 89,020.11 31.45 20,141.50 19.94 1,936 38.82 44.40
879.20 88,468.09 19.97 19,831.50 13.82 3,831 29.92 45.15
30,230.25 64,237.17 48.58 6,097.20 10.80 1,201 16.01 58.42
1,103.95 64,117.60 17.97 29,559.20 17.55 3,169 -10.04 42.48
Growth Rate
Revenue Growth
-11.74 %
Net Income Growth
2,442.60 %
Cash Flow Change
-30.32 %
ROE
3,990.54 %
ROCE
-1,472.62 %
EBITDA Margin (Avg.)
-165.04 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
303
344
360
392
335
356
350
309
353
404
435
454
412
405
105
367
337
342
402
385
354
426
212
301
364
347
302
Expenses
263
295
294
321
267
283
266
247
265
300
321
345
315
330
199
349
318
311
350
332
333
393
436
412
322
286
243
EBITDA
40
49
66
71
68
73
84
62
88
104
114
109
97
75
-94
18
20
31
52
53
21
34
-224
-111
43
62
59
Operating Profit %
13 %
14 %
17 %
17 %
19 %
19 %
23 %
17 %
24 %
25 %
25 %
22 %
22 %
18 %
-98 %
3 %
4 %
8 %
11 %
13 %
5 %
8 %
-106 %
-38 %
12 %
18 %
19 %
Depreciation
19
19
21
23
23
24
24
24
26
28
27
27
28
28
28
28
28
29
28
27
26
26
26
25
25
25
25
Interest
18
20
23
22
19
20
19
20
20
19
21
25
19
17
18
22
23
22
24
22
25
24
25
31
31
28
27
Profit Before Tax
3
9
22
26
27
29
41
18
42
57
66
57
50
30
-140
-31
-31
-19
1
5
-29
-17
-275
-167
-14
8
8
Tax
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
-33
-15
-9
0
1
-10
0
0
89
0
0
0
Net Profit
3
9
22
26
27
29
41
18
42
57
66
57
50
30
-140
2
-17
-10
0
4
-19
-17
-275
-255
-14
8
8
EPS in ₹
0.23
3.47
8.96
10.17
10.29
11.21
16.00
6.78
15.75
19.21
18.47
15.57
13.95
8.27
-38.93
0.53
-4.56
-2.77
0.12
1.05
-5.43
-4.77
-72.07
-70.93
-3.50
2.54
2.03

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,822
1,960
2,154
2,614
2,945
2,899
2,351
Fixed Assets
1,086
1,218
1,397
1,382
1,356
1,364
1,268
Current Assets
608
648
672
1,058
1,239
1,188
801
Capital Work in Progress
72
40
41
88
239
239
256
Investments
1
0
0
0
0
2
2
Other Assets
663
702
716
1,144
1,350
1,295
825
Total Liabilities
1,822
1,960
2,154
2,614
2,945
2,899
2,351
Current Liabilities
738
656
730
789
1,063
1,101
1,243
Non Current Liabilities
315
344
333
232
354
296
172
Total Equity
769
960
1,090
1,593
1,527
1,502
937
Reserve & Surplus
739
826
963
1,553
1,489
1,464
898
Share Capital
25
26
27
36
36
36
36

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
32
30
-20
142
-151
-38
-0
Investing Activities
-86
-113
-359
-106
-243
-81
-4
Operating Activities
49
166
242
156
-242
156
109
Financing Activities
68
-23
97
93
334
-113
-106

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
44.11 %
41.07 %
41.07 %
39.51 %
39.71 %
40.40 %
40.40 %
40.40 %
40.97 %
39.31 %
37.19 %
30.49 %
30.49 %
37.27 %
37.27 %
37.23 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
15.80 %
14.00 %
14.25 %
14.67 %
DIIs
3.72 %
6.18 %
5.55 %
5.38 %
3.39 %
2.85 %
2.56 %
3.01 %
2.22 %
1.75 %
1.75 %
1.71 %
2.97 %
2.83 %
3.38 %
3.19 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
14.76 %
14.35 %
13.84 %
16.36 %
17.41 %
16.61 %
17.28 %
16.54 %
16.23 %
18.06 %
19.84 %
20.95 %
20.15 %
19.61 %
18.83 %
21.93 %
Others
37.41 %
38.40 %
39.53 %
38.73 %
39.48 %
40.15 %
39.76 %
40.04 %
40.58 %
40.88 %
41.22 %
46.84 %
30.59 %
26.29 %
26.28 %
22.98 %
No of Share Holders
58,907
67,197
65,449
73,000
77,228
82,710
83,319
79,149
76,325
75,417
74,473
72,918
73,912
78,617
71,882
83,148

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 5 2 7 0.00 3 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 1.22 0.16 1.14 0.00 0.88 0.00 0.00

Corporate Action

Announcements

Grant Of ESOP Options
Feb 21, 2025, 17:58
Closure Of Wholly Owned Subsidiary
Feb 21, 2025, 17:51
Announcement under Regulation 30 (LODR)-Resignation of Managing Director
Feb 21, 2025, 17:39
Announcement under Regulation 30 (LODR)-Change in Management
Feb 21, 2025, 17:32
Announcement under Regulation 30 (LODR)-Change in Directorate
Feb 21, 2025, 17:24
Board Meeting Outcome for Solara Active Pharma Sciences Limited Has Informed The Exchange Regarding Board Meeting Held On February 21 2025 Interalia To Consider Changes In Management And Directorate C
Feb 21, 2025, 17:16
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Feb 10, 2025, 15:04
Announcement under Regulation 30 (LODR)-Meeting Updates
Feb 07, 2025, 10:32
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Jan 31, 2025, 14:57
Integrated Filing (Financial)
Jan 29, 2025, 14:53
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 25, 2025, 22:03
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jan 24, 2025, 17:48
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jan 24, 2025, 17:05
Statement Of Deviation And Variation
Jan 24, 2025, 15:15
Financial Results
Jan 24, 2025, 14:46
Announcement Under Regulation 30 (LODR) - Update
Jan 24, 2025, 14:40
Board Meeting Outcome for Outcome Of The Board Meeting
Jan 24, 2025, 14:35
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 16, 2025, 11:49
Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Scheduled On 24/01/2025 Inter Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For
Jan 16, 2025, 11:43
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 13, 2025, 15:52
Closure of Trading Window
Dec 27, 2024, 11:17
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Nov 12, 2024, 12:49
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Oct 28, 2024, 11:34
Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 23, 2024, 09:51
Statement Of Deviation And Utilization Of Funds For The Quarter Ended September 30, 2024
Oct 21, 2024, 19:31
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Oct 21, 2024, 19:17
Financial Results
Oct 21, 2024, 14:29
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Oct 21, 2024, 14:20
Board Meeting Outcome for Outcome Of The Board Meeting Held On October 21, 2024
Oct 21, 2024, 13:58
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 14, 2024, 19:13
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Oct 14, 2024, 16:33
Board Meeting Intimation for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024
Oct 14, 2024, 16:24
Closure of Trading Window
Sep 30, 2024, 15:37
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 24, 2024, 09:38
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 20, 2024, 12:39
Revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
Aug 30, 2024, 10:51
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Aug 30, 2024, 10:10
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 29, 2024, 15:07
Business Responsibility and Sustainability Reporting (BRSR)
Aug 28, 2024, 16:01
Closure Of Register Of Members And Share Transfer Books
Aug 28, 2024, 15:56
Notice Of The Seventh Annual General Meeting Of The Company For The Financial Year 2023-24
Aug 28, 2024, 15:44
Reg. 34 (1) Annual Report.
Aug 28, 2024, 15:37
Newspaper Advertisement Before Dispatch Of Notice Of The Seventh Annual General Meeting
Aug 26, 2024, 11:51
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 09, 2024, 15:29
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jul 31, 2024, 14:35
Resignation Letter Of Director
Jul 29, 2024, 16:05
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Jul 29, 2024, 16:01
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Jul 26, 2024, 20:13
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jul 23, 2024, 13:49
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jul 22, 2024, 17:28

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
48.65
ATR(14)
Volatile
29.36
STOCH(9,6)
Neutral
74.93
STOCH RSI(14)
Overbought
90.14
MACD(12,26)
Bullish
10.17
ADX(14)
Strong Trend
33.91
UO(9)
Bearish
50.40
ROC(12)
Uptrend And Accelerating
11.48
WillR(14)
Neutral
-30.20